Needle-Free Weight Loss: What the Oral GLP-1 Option Means for Patients
November 18, 2025
Important Note: Orforglipron is not yet FDA-approved. Eli Lilly plans to submit for regulatory review in late 2025, with potential approval expected in 2026.For millions of [...]